Biofrontera (BFRI)

• Market cap: $16.2M
• 1 day: -3.54%
• 5 days: -6.84%
• 1 month: -28.76%
• 3 months: 6.86%
• 6 months: 39.94%
• Year to date: 50.34%
• 1 year: 12.61%
• 5 years: -98.76%
• 10 years: -98.76%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

Employees: 94